Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Graves' ophthalmopathy].

Isabelle Badelon1, Serge Morax

  • 1Fondation Ophtalmologique Adolphe de Rothschild, Service du Dr Serge Morax, 75019, Paris. isabelle.badelon@avc.ap-hop-paris.fr

La Revue Du Praticien
|April 14, 2005
PubMed
Summary

Graves' ophthalmopathy (GO) is an autoimmune condition affecting eye tissues, often linked to Graves' disease. While most cases are mild, severe GO can cause vision loss and significantly impact quality of life.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Adult Onset Asthma and Periocular Xanthogranuloma (AAPOX), a Rare Entity With a Strong Link to IgG4-Related Disease: An Observational Case Report Study.

Medicine·2015
Same author

Takayasu disease revealed by bilateral loss of vision.

Retinal cases & brief reports·2014
Same author

IgG4-related diffuse perineural disease.

Neurology·2014
Same author

Adult-onset asthma associated with periocular xanthogranuloma: new diagnostic and therapeutic approaches in a very rare systemic disease.

Ophthalmic plastic and reconstructive surgery·2013
Same author

Inaugural severe vaso-occlusive retinopathy in systemic lupus erythematosus.

International ophthalmology·2012
Same author

Dysthyroid optic neuropathy: atypical initial presentation and persistent visual loss.

Orbit (Amsterdam, Netherlands)·2009

Area of Science:

  • Endocrinology and Immunology
  • Ophthalmology

Context:

  • Graves' ophthalmopathy (GO) is a chronic autoimmune condition impacting retrobulbar tissues.
  • It is etiologically linked to Graves' disease, with incompletely understood pathogenesis.
  • Symptoms range from proptosis and extraocular muscle dysfunction to eyelid changes.

Purpose:

  • To provide an overview of Graves' ophthalmopathy.
  • To describe its clinical manifestations and impact on quality of life.
  • To outline established treatments for severe and active disease.

Summary:

  • GO affects the tissues around the eye, driven by autoimmune processes.
  • Severe manifestations, though infrequent, can be disfiguring and sight-threatening.
  • Standard treatments for severe GO include glucocorticoids, orbital radiotherapy, and surgery.

Impact:

  • Highlights the significant quality of life impairment in severe GO cases.
  • Emphasizes the need for effective management strategies for this debilitating condition.
  • Informs clinicians and patients about the established therapeutic options for severe Graves' ophthalmopathy.

Related Experiment Videos